Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion

The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are to assess rates of follow-up, adherence, efficacy, complications, lost productivity, and to estimate the minimum proportion of women who choose home-use over clinic use of mifepristone.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Termination of Pregnancy

Age range

18 year–55 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Municipal Clinical Hospital, Chisinau, Moldova

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Reproductive age women seeking abortion services.
Eligible women will be in general good health and assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken.
Participants must be eligible for medical abortion according to clinician and clinic standards.
In the United States, women only 18 years and older will be eligible to participate, unless the study site obtains a waiver to include minors.

Treatment and study plan

Mifepristone

Drug

home administration of mifepristone

Primary outcomes

Proportion of women who select home-use of mifepristone

Time frame: 1-2 weeks
Satisfaction with Method

Time frame: 1-2 weeks

Sponsors and collaborators

Lead sponsor

Gynuity Health Projects

Other

Registry information

Important dates

Study start: 2009
Primary completion: 2011
Study completion: 2011
First posted: Oct 14, 2009
Registry last updated: Apr 17, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed